Valeo Financial Advisors LLC Acquires Shares of 1,727 Align Technology, Inc. $ALGN

Valeo Financial Advisors LLC acquired a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,727 shares of the medical equipment provider’s stock, valued at approximately $327,000.

Several other institutional investors have also bought and sold shares of the business. Redmond Asset Management LLC boosted its holdings in Align Technology by 2.0% during the first quarter. Redmond Asset Management LLC now owns 2,769 shares of the medical equipment provider’s stock worth $440,000 after buying an additional 54 shares in the last quarter. Horizon Investments LLC boosted its holdings in Align Technology by 6.2% during the first quarter. Horizon Investments LLC now owns 1,018 shares of the medical equipment provider’s stock worth $162,000 after buying an additional 59 shares in the last quarter. Washington Trust Advisors Inc. boosted its holdings in Align Technology by 5.2% during the first quarter. Washington Trust Advisors Inc. now owns 1,205 shares of the medical equipment provider’s stock worth $191,000 after buying an additional 60 shares in the last quarter. Covestor Ltd boosted its holdings in Align Technology by 18.8% during the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after buying an additional 78 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 92 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Insider Activity at Align Technology

In other Align Technology news, CEO Joseph M. Hogan bought 7,576 shares of Align Technology stock in a transaction dated Friday, August 1st. The stock was acquired at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the transaction, the chief executive officer directly owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. This represents a 4.27% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.66% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently issued reports on ALGN shares. Morgan Stanley reissued an “equal weight” rating and set a $154.00 price target (down from $249.00) on shares of Align Technology in a report on Thursday, July 31st. Weiss Ratings downgraded shares of Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. Stifel Nicolaus lowered their price target on shares of Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a report on Thursday, July 31st. Wells Fargo & Company lowered their price target on shares of Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a report on Thursday, July 31st. Finally, Piper Sandler decreased their price objective on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating on the stock in a report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $210.00.

Align Technology Stock Down 0.9%

Shares of NASDAQ ALGN opened at $131.87 on Friday. The firm has a 50-day simple moving average of $135.83 and a 200-day simple moving average of $164.70. The stock has a market capitalization of $9.56 billion, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 1.51 and a beta of 1.70. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $246.19.

Align Technology (NASDAQ:ALGN) last issued its earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). The business had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. Align Technology’s quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter last year, the company earned $2.41 earnings per share. Align Technology has set its Q3 2025 guidance at EPS. As a group, equities research analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology announced that its board has initiated a stock buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to purchase up to 2% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.